Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration (PDEX)
This study is ongoing, but not recruiting participants.
Study NCT00390208 Information provided by Bay Area Retina Associates
First Received: October 17, 2006 Last Updated: November 16, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Age Related Macular Degeneration
Additional conditions recognized in this trial
Macular Degeneration
More general conditions related to this trial
Eye Diseases
Retinal Degeneration
Retinal Diseases
Interventions listed in this trial
Ranibizumab
Additional drug interventions recognized in this trial
Antibodies, Monoclonal
Dexamethasone
Dexamethasone acetate
Verteporfin
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antiemetics
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Autonomic Agents
Central Nervous System Agents
Dermatologic Agents
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Peripheral Nervous System Agents
Pharmacologic Actions
Photosensitizing Agents
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Bay Area Retina Associates
QLT Inc
Back to top of Main Content
